Takara Bio Inc
F:TF2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takara Bio Inc
F:TF2
|
JP |
|
C
|
Cyberark Software Ltd
F:CYB
|
IL |
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
MaxCyte Inc
F:MYE0
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TF2's stock price target?
Not Available
TF2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Takara Bio Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 9%.
What is the Gross Profit forecast for Takara Bio Inc?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 2 years is 14%.